Frontage Welcomes Glenn Washer, BSc, DABT as Executive Vice President, Global Safety & Toxicology Services

EXTON, Pa., March 10, 2020 /PRNewswire/ — Frontage Laboratories is pleased to announce that Glenn Washer, BSc, DABT has joined Frontage as our Executive Vice President, Global Safety & Toxicology Services.  Glenn will report directly to Dr. Song Li, CEO.

Glenn has more than 35 years of experience in increasingly responsible roles within the realm of Safety/Toxicology at various companies.  In his most recent position, Glenn served as the President, Charles River Laboratories, Montreal, Canada and as the Corporate Senior Vice President, for Charles River’s North America Safety Assessment sites.  He brings a wealth of knowledge and experience to his new role, including extensive executive management experience and P&L responsibility in regulated contract research and biopharmaceuticals industries with emphasis on multi-site, multi-national CRO management, research & development.  Glenn has in-depth knowledge and experience in operations management, M&A due diligence, integration of new acquisitions, organizational restructuring, and strategic planning.

Glenn will be responsible for the overall leadership and the strategic global growth of the Safety/Toxicology business at Frontage Laboratories. 

“We’re very excited to welcome Mr. Glenn Washer onboard as our Executive Vice President, Global Safety and Toxicology”, said Dr. Song Li, CEO of Frontage Laboratories, “Mr. Washer’s experience in preclinical drug development, safety and toxicology, translational science and medicine makes him ideally suited to taking this role. We have confidence in his leadership to strengthen Frontage’s capabilities and capacities in preclinical development globally”.

Mr. Washer commented: “I am very excited to be joining the impressive team at Frontage.  Their leadership team’s dedication to the highest levels of scientific rigor, quality, customer service, and employee development give me great confidence that we share the same values and vision.  I look forward to the opportunity to contribute to the continued growth of this exceptional global organization.”

For more information: https://www.frontagelab.com/about/news-item/frontage-welcomes-glenn-washer/

Contact: Shannon C. Ryan
Sryan@frontagelab.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/frontage-welcomes-glenn-washer-bsc-dabt-as-executive-vice-president-global-safety–toxicology-services-301020707.html

SOURCE Frontage Laboratories, Inc.

Staff

Recent Posts

Castle Biosciences Announces Updates to its Board of Directors

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that…

2 hours ago

Akanda Corp. Announces Closing of Underwritten Public Offering

London, United Kingdom--(Newsfile Corp. - March 27, 2024) - On March 24, 2024, Akanda Corp.…

2 hours ago

Dermata to Present at the Emerging Growth Conference on April 3, 2024

- Dermata to provide a corporate update followed by a live question and answer session…

2 hours ago

CorDx Receives Emergency Use Authorization (EUA) for 10-Min Flu A/B & COVID-19 Test

FDA Grants CorDx Emergency Use Authorization for Multi-Target Rapid Test for Flu A/B & COVID-19SAN…

5 hours ago

Greenway Health and DrFirst Partner to Improve Medication Adherence and Improve Patient Outcomes through Technology

TAMPA, Fla., March 27, 2024 /PRNewswire/ -- Greenway Health, a leading health information technology services provider, announced its strategic…

8 hours ago

NextGen Healthcare Named to Newsweek List of America’s Most Trustworthy Companies for Third Year in a Row

List Based on an Independent Survey of 25,000 U.S. ResidentsREMOTE-FIRST COMPANY/NEW YORK--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare, a…

8 hours ago